-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Assumes Centessa Pharmaceuticals at Overweight, Maintains Price Target of $27

Benzinga·03/07/2025 17:14:20
Listen to the news
Morgan Stanley analyst Jeffrey Hung assumes Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight rating and maintains Price Target of $27.